Literature DB >> 11944866

Oral fluorescein angiography with scanning laser ophthalmoscope.

C J Argento1, O R Lopez Mato, M D Martinez-Cartier.   

Abstract

OBJECTIVE: To study the efficacy of oral fluorescein angiography compared to intravenous (IV) fluorescein angiography in several retinal diseases. PATIENTS AND METHODS: We performed oral fluorescein angiography with a confocal SLO (Heidelberg Retina Angiograph-HRA) in fourteen psychologically challenged individuals and children, all of whom explicitly refused venipuncture. Patient's diagnosis included diabetes, central serous choroidopathy, toxoplasmosis and choroidal neovascularization. A dose of 30 mg/kg body weight of fluorescein was given.
RESULTS: We obtained images of adequate quality to allow interpretation in all cases.
CONCLUSIONS: Even though the images were not nearly as good as when obtained after IV injection, we conclude that oral fluorescein angiography with SLO is an appropriate alternative in those cases where a venipuncture is contraindicated by medical or psychological reasons.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11944866     DOI: 10.1023/a:1014423202279

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  3 in total

1.  Oral fluorescein angiography: reassessment of its relative safety and evaluation of optimum conditions with use of capsules.

Authors:  A P Watson; E S Rosen
Journal:  Br J Ophthalmol       Date:  1990-08       Impact factor: 4.638

Review 2.  Fluorescein angiography complication survey.

Authors:  L A Yannuzzi; K T Rohrer; L J Tindel; R S Sobel; M A Costanza; W Shields; E Zang
Journal:  Ophthalmology       Date:  1986-05       Impact factor: 12.079

3.  Oral fluorescein angiography and fluoroscopy: determination of plasma fluorescein levels and clinical application.

Authors:  F Gómez-Ulla; A Malvar; M Parafita; P Polo; I Seoane
Journal:  Optom Vis Sci       Date:  1992-12       Impact factor: 1.973

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.